Insulin-like growth factor-I expression in normal and diseased endometrium

International Journal of Cancer

Volumn 80, Issue 2, 1999, Pages 188-193

  Maiorano, Eugenio ^a,b   Loverro, Giuseppe ^a   Viale, Giuseppe ^c   Giannini, Teresa ^d   Napoli, Anna ^a   Perlino, Elda ^c  

^a UNIVERSITY OF BARI   (Italy)

^b POLICLINICO   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN;

ADULT; ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOMETRIUM; ENDOMETRIUM CANCER; FEMALE; HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH;

ADULT; AGED; AGED, 80 AND OVER; BLOTTING, NORTHERN; CASE-CONTROL STUDIES; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; MIDDLE AGED; REFERENCE VALUES; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA;

EID: 0033579911     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990118)80:2<188::AID-IJC5>3.0.CO;2-E     Document Type: Article

References (34)

1. ABBOTT, A.M., BUENO, R., PEDRINI, M.T., MURRAY, J.M. and SMITH, R.J., Insulin-like growth factor I receptor gene structure. J. biol. Chem., 267, 10759-10763 (1992).
2. AYABE, T., TSUTSUMI, O., SAKAI, H., YOSHIKAWA, H., YANO, T., KURIMOTO, F. and TAKETANI, Y., Increased circulating levels of insulin-like growth factor-I and decreased circulating levels of insulin-like growth factor binding protein-1 in postmenopausal women with endometrial cancer. Endocrinol. J., 44, 419-424 (1997).
3. BALLARD, F.J., WALLACE, J.C., FRANCIS, G.L., READ, L.C. and TOMAS, F.M., Des (1-3) IGF-I: a truncated form of insulin-like growth factor-I. Int. J. Biochem. Cell Biol., 28, 1085-1087 (1996).
4. BELL, G.I., MERRYWEATHER, J.P., SANCHEZ-PESCADOR, R., STEMPIEN, M.M., PRIESTLEY, L., SCOTT, J. and RALL, L.B., Sequence of a cDNA clone encoding human preproinsulin-like growth factor II. Nature (Lond.), 310, 775-777 (1984).
5. BERCHUCK, A. and BOYD, J., Molecular basis of endometrial cancer. Cancer (Suppl.), 76, 2034-2040 (1995).
6. BHATIA, P., TAYLOR, W.R., GREENBERG, A.H. and WRIGHT, J.A., Comparison of glyceraldehyde-3-phosphate dehydrogenase and 28S-ribosomal RNA gene expression as RNA loading controls for Northern blot analysis of cell lines of varying malignant potential. Anal. Biochem., 216, 223-226 (1994).
7. CHIRGWIN, J.M., PRZYBYLA, A.E., RAYMOND, J.M. and RUTTER, W.J., Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry, 18, 5294-5299 (1979).
8. CLINE, M.J., Overview: the nature of malignancy. In N. Shaun and B. Thomas (eds.), Apoptosis and cell cycle control in cancer, pp. 131-146. Latchman, London (1996).
9. DAUGHADAY, W.H., Editorial: the possible autocrine, paracrine and endocrine roles of insulin-like growth factors of human tumours. Endocrinology, 127, 1-4 (1990).
10. DAUGHADAY, W.H. and ROTWEIN, P., Insulin-like factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum and tissue concentrations. Endocrinol. Rev., 10, 68-91 (1989).
11. D'ERCOLE, J.A., STILES, A.D. and UNDERWOOD, L.E., Tissue concentrations of somatomedin C: further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action. Proc. nat. Acad. Sci. (Wash.), 81, 935-939 (1984).
12. ELKAS, J., GRAY, L.K., HOWARD, L., PETIT, N., POHL, J. and ARMSTRONG, A., The effects of tamoxifen on endometrial insulin-like growth factor-I expression. Obstet. Gynecol., 91, 45-50 (1998).
13. FAUSTO, N., Multifunctional roles for transforming growth factor beta 1. Lab. Invest., 65, 497-499 (1991).
14. FEINBERG, A.R. and VOGELSTEIN, B., A technique for radiolabelling DNA restriction endonuclease fragment to high specific activity. Anal. Biochem., 132, 6-13 (1983).
15. GIUDICE, L.C., Growth factors and growth modulators in human uterine endometrium: their potential relevance to reproduction medicine. Fertil. Steril., 61, 1-17 (1994).
16. GIUDICE, L.C., DSUPIN, B.A. and IRWIN, J.C., Steroid and peptide regulation of insulin-like growth factor binding proteins secreted by human endometrial stromal cells is dependent on stromal differentiation. J. clin. Endocrinol. Metab., 75, 1235-1241 (1992).
17. GIUDICE, L.C., DSUPIN B.A., JIN, I.H., VU, T.H. and HOFFMAN, A.R., Differential expression of mRNAs encoding insulin-like growth factors and their receptors in human uterine endometrium and decidua. J. clin. Endocrinol. Metab., 76, 1115-1122 (1993).
18. GURPIDE, E., Endometrial cancer: biochemical and clinical correlates. J. nat. Cancer Inst., 83, 405-416 (1991).
19. JONES, J. and CLEMMONS, D.R., Insulin-like growth factors and their binding proteins: biological actions. Endocrinol. Rev., 16, 3-34 (1995).
20. LAATIKAINEN, T.J., TOMAS, E.I. and VOUTILAINEN, R.J., The expression of insulin-like growth factor and its binding protein mRNA in the endometrium of postmenopausal patients with breast cancer receiving tamoxifen. Cancer, 76, 1406-1410 (1995).
21. MACAULAY, V.M., Insulin-like growth factors and cancer. Brit. J. Cancer, 65, 311-320 (1992).
22. PEKONEN, F., NYMAN, T. and RUTANEN, E.M., Human endometrial adenocarcinoma cell lines HEC 1B and KLE secrete insulin-like growth factor binding protein-1 and contain IGF-I receptors. Mol. cell. Endocrinol., 75, 81-87 (1991).
23. PERLINO, E., LOVERRO, G., MAIORANO, E., GIANNINI, T., NAPOLI, A., FIORE, M.G., RICCO, R., MARRA, E. and SELVAGGI, L., Down-regulated expression of transforming growth factor-β1 in endometrial tissues. Brit. J. Cancer, 77, 1260-1266 (1998).
24. REYNOLDS, R.K., OWENS, C.A. and ROBERTS, J.A., Cultured endometrial cells exhibit autocrine growth factor stimulation that is not observed in cultured normal endometrial cells. Gynecol. Oncol., 60, 380-386 (1996).
25. REYNOLDS, R.K., OWENS, C.A., ROBERTS, J.A., HOPKINS, M.P. and MENON, K.M.J., Autocrine production of TGF-α and IGF-I causes proliferation in endometrial carcinoma cell lines. Gynecol. Oncol., 54, 106-107 (1994).
26. ROTWEIN, P., Two insulin-like growth factor I messenger RNAs are expressed in human liver. Proc. nat. Acad. Sci. (Wash.), 83, 77-81 (1986).
27. RUTANEN, E.M., NYMAN, T., LEHTOVIRTA, P., AMMALA, M. and PEKONEN, F., Suppressed expression of insulin-like growth factor binding protein 1 mRNA in the endometrium: a molecular mechanism associating endometrial cancer with its risk factors. Int. J. Cancer, 59, 307-312 (1994).
28. RUTANEN, E.M., PEKONEN, F., NYMAN, T. and WAHLSTROM, T., Insulin-like growth factors and their binding proteins in benign and malignant uterine disease. Growth Regul., 3, 74-77 (1993).
29. SMITH, S.K., Growth factors in the human endometrium. Hum. Reprod. Update, 9, 936-946 (1994).
30. TALAVERA, F., REYNOLDS, R.K., ROBERTS, J.A. and MENON, K.M.J., Insulin-like growth factor-I receptors in normal and neoplastic human endometrium. Cancer Res., 50, 3019-3024 (1990).
31. VAN NOORDEN, S., Tissue preparation and immunostaining techniques for light microscopy. In J.M. Polak and S. Van Noorden (eds.), Immunocytochemistry: modern methods and applications, pp. 47-48, Wright, Bristol (1986).
32. YEE, D., MORALES, F.R., HAMILTON, T.C. and VON HOFF, D.D., Expression of insulin-like growth factor 1, its binding proteins, and its receptor in ovarian cancer. Cancer Res., 51, 5107-5112 (1991).
33. YEE, D., PAIK, S., LEBOVIC, G.S., MARCUS, R.R., FAVONI, R.E., CULLEN, K.J., LIPPMAN, M.E. and ROSEN, N., Analysis of insulin-like growth factor I gene expression in malignancy: evidence for a paracrine role in human breast cancer. Mol. Endocrinol., 3, 509-517 (1989).
34. ZHOU, J., DSUPIN, B.A., GIUDICE, L.C. and BONDY, C.A., Insulin-like growth factor system gene expression in human endometrium during the menstrual cycle. J. clin. Endocrinol. Metab., 79, 1723-1734 (1994).